BioWare Technologies Co., Ltd. was established on 12th August 2000. The Capital is 219,000,000 at present. The management team includes the elites from domestic and foreign universities and research units.

      BioWare's strategies are developing the Bio-Tech products for livelihood with high profit. The products are derived directly or indirectly from various microorganisms and their metabolites. Using mass fermentation techniques to develop products with high additional value. The sophisticate technologies in gene and protein engineering are undergone for special products of agriculture, medical care and environmental protection with high benefit. It will provide great offering for national biotech industry and abundant returning interests.